Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01852591 · OUTCOME

Number of Participants With Immune Response

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant · Source last updated 2017-02-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
30 Days Post Vaccine

What was measured

Positive response per test category. Post-vaccination result higher than pre-vaccination values for each test category criteria. Additional details are reported under Secondary Outcome Measures.

Analysis population: All evaluable participants.

Groups in this outcome

Experimental: PCV 13

Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Experimental: PCV 135

Reported measurements

CD4+CTV-IFN-gamma+,
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Experimental: PCV 135Not reportedNot reportedNot reportedNot reported
CD8+CTV-IFN-gamma+,
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Experimental: PCV 135Not reportedNot reportedNot reportedNot reported
CD8+CD107a+
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Experimental: PCV 135Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    title
    CD4+CTV-IFN-gamma+,
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    title
    CD8+CTV-IFN-gamma+,
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        5
    title
    CD8+CD107a+
denoms
  1. counts
    1. group Id
      OG000
      value
      5
    units
    Participants
description
Positive response per test category. Post-vaccination result higher than pre-vaccination values for each test category criteria. Additional details are reported under Secondary Outcome Measures.
groups
  1. description
    Pneumococcal conjugate vaccine (PCV 13), 0.5ml, 3 to 30 days prior to transplant and then again at 7-10 and 21-24 days after transplant.
    id
    OG000
    title
    Experimental: PCV 13
param Type
NUMBER
population Description
All evaluable participants.
reporting Status
POSTED
time Frame
30 Days Post Vaccine
title
Number of Participants With Immune Response
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice